Roman Butler Fullerton & CO Abbott Laboratories Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 3,748 shares of ABT stock, worth $445,824. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,748

Previous 3,862 2.95%

Holding current value

$445,824

Previous $401,000 6.48%

% of portfolio

0.13%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $11,407 - $13,466	-114 Reduced 2.95%	3,748 $427,000
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $635,807 - $709,721	-6,312 Reduced 62.04%	3,862 $401,000
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $34,498 - $38,102	-315 Reduced 3.0%	10,174 $1.16 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $811 - $993	9 Added 0.09%	10,489 $1.15 Million
Q3 2023 Oct 18, 2023	SELL	$95.53 - $114.62 $3,439 - $4,126	-36 Reduced 0.34%	10,480 $1.01 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $123,657 - $137,779	-1,227 Reduced 10.45%	10,516 $1.15 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $10,654 - $12,541	110 Added 0.95%	11,743 $1.19 Million
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $54,469 - $63,900	-573 Reduced 4.69%	11,633 $0
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $1,064 - $1,232	11 Added 0.09%	12,206 $1.24 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $1,224 - $1,480	12 Added 0.1%	12,195 $1.33 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $1,140 - $1,390	10 Added 0.08%	12,183 $1.44 Million
Q4 2021 Jan 24, 2022	BUY	$115.53 - $141.46 $2,310 - $2,829	20 Added 0.16%	12,173 $1.71 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $7,299 - $8,592	69 Added 0.57%	12,153 $1.41 Million
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $1,260 - $1,373	12 Added 0.1%	12,084 $1.32 Million
Q3 2020 Oct 15, 2020	BUY	$91.64 - $111.29 $1,191 - $1,446	13 Added 0.11%	12,072 $1.31 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $14,165 - $18,130	-185 Reduced 1.51%	12,059 $1.1 Million
Q1 2020 Apr 13, 2020	BUY	$62.82 - $91.86 $16,270 - $23,791	259 Added 2.16%	12,244 $966,000
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $24,730 - $27,531	315 Added 2.7%	11,985 $1.04 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $39,610 - $42,950	-484 Reduced 3.98%	11,670 $976,000
Q2 2019 Jul 22, 2019	BUY	$72.88 - $85.0 $23,321 - $27,200	320 Added 2.7%	12,154 $1.02 Million
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $54,697 - $66,129	826 Added 7.5%	11,834 $946,000
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $721,684 - $817,564	11,008 New	11,008 $760,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Abbott Laboratories Transaction History